BioCentury | Jun 9, 2016
Distillery Therapeutics

Therapeutics: Glutathione S-transferase pi 1 (GSTP1)

Cancer INDICATION: Breast cancer Patient sample, cell culture and mouse studies suggest inhibiting GSTP1 could help treat triple-negative breast cancer (TNBC). Levels of GSTP1 were higher in TNBC cell lines and TNBC tumor samples from...
BioCentury | Feb 4, 2013
Company News

Epigenomics, Predictive Biosciences sales and marketing update

The partners said Predictive Biosciences launched a biopsy test to diagnose prostate cancer in the U.S. that incorporates Epigenomics' glutathione S-transferase pi 1 ( GSTP1 ) DNA methylation marker. In 2010, Predictive exercised a 2009 option to...
Items per page:
1 - 2 of 2